Addressing the source of Parkinson's disease
Research Grant Recipient: Jonathan S. Marchant, PhD
Grant Period: 2016-2018
Award Value: $250,000
Site: University of Minnesota
There is a key need to generate new drug treatments for neurodegenerative diseases that stop disease progression rather than just mask symptoms. In this regard, our team has recently discovered that analogs of NAADP - a potent second messenger - are able to reverse cellular defects seen in cells isolated from patients with Parkinson’s disease. To understand whether this therapy has clinical potential, we need to optimize the properties of these NAADP analogs for use in vivo and assess the beneficial effects of newly generated lead compounds in assays of neuronal regeneration and viability.
Dr. Marchant is a Professor in the Department of Pharmacology and a member of the Stem Cell Institute at the University of Minnesota.